- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00032448
Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?
CSP #456 - Tension Free Inguinal Hernia Repair: Comparison of Open and Laparoscopic Surgical Techniques
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Hypothesis: Open tension-free herniorrhaphy when compared with laparoscopic herniorrhaphy will achieve equal or better recurrence rates and lower costs while achieving equivalent outcomes for patient-centered measures.
Secondary Hypotheses:
Intervention: Patients randomized to open repair will undergo a standardized tension-free herniorrhaphy with prosthesis (method of Lichtenstein). Patients randomized to laparoscopic herniorrhaphy will undergo a standardized preperitoneal repair with prosthesis, using either a transperitoneal or extraperitoneal approach. During the implementation period of the trial, a preliminary laboratory session will be conducted with all site PIs to standardize herniorrhaphy techniques, reach consensus on all aspects of perioperative patient management (including postoperative patient instructions, follow-up schedules, definitions of recurrence and complications), and to ensure that the site PI is thoroughly familiar with the protocol.
Each site will be visited by one of two expert surgeons (the Study Chair or a Co-PI surgeon) to observe the operative procedures and ensure that participating surgeons adhere to the protocol in all respects. The first visit will take place in the first 6 months of the study and then as needed thereafter, based on routine examination of operative records randomly selected from each site (5 open and 5 laparoscopic herniorrhaphies, and, if appropriate, viewing of videotapes of the laparoscopic procedures).
Primary Outcomes: Hernia recurrence rate.
Study Abstract:
Background: Inguinal hernia is one of the most common worldwide afflictions of men. The presence of an inguinal hernia is indication for its repair. Approximately 700,000 hernia repairs are performed in the U.S. each year, and this procedure accounts for 10% of all general surgery procedures in the Veterans Health Administration (VHA) (10,000 inguinal herniorrhaphies performed per year). There are many different techniques currently in use for repairing inguinal hernias and with the advent of laparoscopy, yet another technique is being advocated. Laparoscopic repair has been reported in some studies to be superior to open repair because of less pain and earlier return to work. However, laparoscopic repair requires a general or regional anesthetic and expensive equipment and supplies to perform. There is also evidence that open tension-free mesh repair may have results similar to laparoscopic repair for these patient centered outcome measures. The general acceptance of this procedure, especially in the VHA, has not been uniform. Furthermore, no randomized trial of sufficient size and power to be conclusive has been done to set forth the operative gold standard for hernia repair.
Objectives: To determine whether open tension-free herniorrhaphy when compared with laparoscopic herniorrhaphy can achieve equal or better recurrence rates and lower costs while achieving equivalent outcomes for patient-centered measures.
Methods: This multi-center VA cooperative study is enrolling 2200 men with inguinal hernia and randomizing them to one of two operative techniques: open tension-free (Lichtenstein) repair, or laparoscopic preperitoneal repair. The primary outcome measure is recurrence at two years. Secondary outcome measures are complications, pain, time to return to normal activities, health-related quality of life, patient satisfaction, caregiver burden, and cost. The role of comorbidity in the outcome will also be determined. The sample size will permit at least 80% power to detect a difference of 3% in 2-year recurrence rates between the two surgical procedures. Fourteen VAMCs are randomizing the 2200 patients over a 3-year accrual period. The study will also have a 2-year follow-up period. All patients will be followed to the end of the study so that follow-up will range from 2-5 years (average 3.5 years).
On November 29, 2001, the Hines Cooperative Studies Human Rights Committee and the Data and Safety Monitoring Board met to review the data from CSP #456. Both committees determined that there were sufficient data to complete the trial without enrolling any additional patients and recommended that enrollment be stopped. There were no safety concerns. Approximately 2,165 patients of a targeted 2,200 had been enrolled at this point. All sites were notified of this within 24 hours of the action.
Main Manuscript:
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- VA Medical Center, Birmingham
-
-
Arkansas
-
No. Little Rock, Arkansas, United States, 72114-1706
- Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
-
-
California
-
San Francisco, California, United States, 94121
- VA Medical Center, San Francisco
-
West Los Angeles, California, United States, 90073
- VA Greater Los Angeles Healthcare System, West LA
-
-
Florida
-
Tampa, Florida, United States, 33612
- James A. Haley Veterans Hospital, Tampa
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- VA Maryland Health Care System, Baltimore
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02130
- VA Medical Center, Jamaica Plain Campus
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- John D. Dingell VA Medical Center, Detroit
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- VA Medical Center, Durham
-
-
South Carolina
-
Columbia, South Carolina, United States, 29209
- WJB Dorn Veterans Hospital, Columbia
-
-
Tennessee
-
Memphis, Tennessee, United States, 38104
- VA Medical Center, Memphis
-
-
Texas
-
Dallas, Texas, United States, 75216
- VA North Texas Health Care System, Dallas
-
Houston, Texas, United States, 77030
- Michael E. DeBakey VA Medical Center (152)
-
-
Utah
-
Salt Lake City, Utah, United States, 84148
- VA Salt Lake City Health Care System, Salt Lake City
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Men with inguinal hernia.
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 1
Open and laparoscopic herniorrhaphy
|
Compare the effect of two typs of operative treatment of inguinal hernia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess recurrence rates, operative complications, pain, convalescent time, health-related quality of life, patient satisfaction, and health care utilization and costs.
Time Frame: Two years
|
Two years
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Leigh A. Neumayer, VA Salt Lake City Health Care System, Salt Lake City
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 456
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Advanced Medical Solutions Ltd.CompletedInguinal Hernia | Hernia | Femoral Hernia | Groin HerniaUnited States
-
Medtronic - MITGCompletedInguinal Hernia | Ventral HerniaUnited States
-
Mette Astrup MadsenCompletedInguinal Hernia | Femoral HerniaDenmark
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
W.L.Gore & AssociatesRecruitingHernia, Hiatal | Hernia, Diaphragmatic | Hernia, Ventral | Incisional HerniaUnited States
-
Hobart HarrisWithdrawnHernia | Ventral Hernia | Abdominal Hernia
-
Foregut Research FoundationNot yet recruitingParaesophageal Hernia | Large Hiatal HerniaUnited States
-
AbbVieNot yet recruiting
-
Prisma Health-UpstateRecruiting
Clinical Trials on Standardized tension-free herniorrhaphy with prosthesis
-
Creighton UniversityNorthwestern University; University of Texas Southwestern Medical Center; University... and other collaboratorsCompletedInguinal HerniasUnited States
-
Harbin Medical UniversityCompletedInguinal Hernia, Without Mention of Obstruction or Gangrene
-
Moscow State University of Medicine and DentistryUnknownUrinary Stress IncontinenceRussian Federation
-
RANDActive, not recruiting